eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2021
vol. 46
 
Share:
Share:
abstract:
Experimental immunology

Time- and dose-dependent inhibition of neutrophil extracellular trap formation by blocking of the interleukin-1 receptor

Hannah Wadehn
1
,
Laia Pagerols Raluy
1
,
Jan Kolman
1
,
Charlotte Duecker
1
,
Magdalena Trochimiuk
1
,
Birgit Appl
1
,
Michael Boettcher
1
,
Konrad Reinshagen
1
,
Julian Trah
1

  1. Department of Pediatric Surgery, University Hospital Hamburg Eppendorf, Germany
(Cent Eur J Immunol 2021; 46 (4): 419-426)
Online publish date: 2021/12/12
View full text Get citation
 
PlumX metrics:
Besides performing phagocytosis and degranulation, neutrophils are capable of eliminating microorganisms by releasing neutrophil extracellular traps (NETs). NET formation was found to be associated with increased mortality in sepsis. During sepsis levels of interleukin 1 (IL-1), a cytokine, increases significantly and also was associated with increased mortality. Blocking of the interleukin 1 (IL-1) receptor by anakinra leads to less NET formation in gout patients. However, NET formation is crucial during infection by trapping pathogens and thereby slowing the process. Total or early blocking of cascades leading to NETs may lead to aggravation of infection in otherwise mild cases. The dose- and time-dependent effect of the IL-1 receptor antagonist anakinra was tested on spontaneous, lipopolysaccharide (LPS)-induced and phorbol-12-myristate 13-acetate (PMA)-induced formation of NETs in vitro. Quantitative detection of NETs was performed for NETspecific proteins and cell-free DNA. Immunostained microscopy imaging was used for visualization.

Our study shows a dose- and time-dependent inhibitory effect of anakinra that involves the change of intracellular calcium mobilization on the formation of NETs in vitro for PMA-stimulated neutrophils but not for LPS-stimulated neutrophils. It may be useful for treatment of sepsis as part of a multimodal treatment concept, but it seems that timing and dose need to be carefully chosen.
keywords:

neutrophil granulocytes, neutrophil extracellular traps, interleukin-1 receptor antagonist, anakinra, sepsis

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.